The classical cadherins (e.g. N-, E-, and P-cadherin) are well established homophilic adhesion molecules; however, the mechanism that governs cadherin specificity remains contentious. The classical cadherins contain an evolutionarily conserved His-Ala-Val (HAV) sequence, and linear peptides harboring this motif are capable of inhibiting a variety of cadherin-dependent processes. We now demonstrate that short cyclic HAV peptides can inhibit N-cadherin function. Interestingly, the nature of the amino acids that flank the HAV motif determine both the activity and specificity of the peptides. For example, when the HAV motif is flanked by a single aspartic acid, which mimics the natural HAVD sequence of N-cadherin, the peptide becomes a much more effective inhibitor of N-cadherin function. In contrast, when the HAV motif is flanked by a single serine, which mimics the natural HAVS sequence of E-cadherin, it loses its ability to inhibit the N-cadherin response. Our results demonstrate that subtle changes in the amino acids that flank the HAV motif can account for cadherin specificity and that small cyclic peptides can inhibit cadherin function. An emerging role for cadherins in a number of pathological processes suggests that the cyclic peptides reported in this study might be developed as therapeutic agents.The classical cadherins are a family of calcium-binding integral membrane glycoproteins that can account for the ability of cells to segregate from each other during development (1-3). In this context cadherins have been shown to regulate epithelial (4), endothelial (5), and neural (6 -8) cell adhesion. N-cadherin is predominantly expressed on neural, endothelial, and invasive cancer cells, whereas E-cadherin is predominantly expressed by epithelial cells (9 -11). The classical cadherins generally promote cell adhesion by interacting with one another in a homophilic manner (12, 13). In addition, the classical cadherins perform numerous other biological functions (1). For example, E-cadherin has been shown to be capable of acting as a tumor suppressor (14,15), and N-cadherin promotes neurite outgrowth (8).The classical cadherins are composed of five extracellular domains, a single transmembrane domain, and two cytoplasmic domains (1,16,17). The first extracellular domain (ECD1) 1 of these cadherins contains an evolutionarily conserved HisAla-Val (HAV) motif (6, 18), and several lines of evidence suggest that this sequence is critical for function. In this context, synthetic peptides containing the HAV motif (for example, N-Ac-LRAHAVDING-NH 2 ) have been shown to be capable of inhibiting cadherin-dependent biological processes, such as myoblast fusion (19), neurite outgrowth (8), and embryo compaction (18). Furthermore, antibodies directed against the HAV sequence are also capable of disrupting cadherin-dependent cell adhesion (5,20,21).Crystal studies have demonstrated that N-cadherin ECD1 monomers will form two types of dimeric structure, one that might reflect a trans adhesion interface, and one that might reflec...